NEWS
You can follow the latest news of MicroViable in this section
New GutAlive®, the anaerobic microbiome collection kit
Checkout our new GutAlive® !! The unique user-friendly, high-capacity device for stool collection sampling and transport in anaerobic conditions that ensures sample stability, microbiota viability and preserves DNA integrity. GutAlive® preserves the [...]
Microviable Therapeutics welcomes Marta Fernández on board.
Marta has a degree in Biology (2014) and a Food Biotechnology Master (2016) at the University of Oviedo, plus a MS in Microbiota, Probiotics and Prebiotics at the European University at Madrid (2021) with MS [...]
Borja Sánchez, co-founder of Microviable Therapeutics, among the 62 most influential scientists.
Asturias has 62 scientists among the most influential in the world. This has been revealed by the latest and prestigious Stanford ranking, which includes the 200,000 researchers -195,605 to be exact- most cited internationally in [...]
Microviable will be attending Bio-Europe 2022
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending BIO-Europe event in Leipzig, Germany, from October 24th to 26th. BIO-Europe® is the preeminent partnering conference for the [...]
Microviable welcomes Pilar Manrique, PhD on board
Welcome Pilar Manrique, PhD on board. Pilar obtained her undergraduate degree in Biotechnology at Universidad Francisco de Vitoria (2009) and her doctorate at Montana State University (2018). Pilar has worked over ten years studying the [...]
Microviable Therapeutics will be presenting at AIMID 2022 Meeting
Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for [...]